Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Improving Compliance With Metformin
This study has been completed.
Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00018616
  Purpose

This is a randomized controlled trial of adherence. The study involves monitoring and managing focused intervention in patients prescribed metformin.


Condition Intervention Phase
Diabetes
Behavioral: MEMS caps
Phase II

Drug Information available for: Metformin Metformin hydrochloride
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Improving Compliance With Metformin

Further study details as provided by Department of Veterans Affairs:

Study Start Date: October 1999
Estimated Study Completion Date: February 2002
Detailed Description:

The active intervention, MEMS Feedback, involves review of patients' medication-taking over the preceding weeks

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Metformin has been prescribed
  • Willing to use medication containers with MEMS caps
  • Capable of giving informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018616

Locations
United States, Connecticut
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
Investigators
Investigator: Michael Rigsby, M.D.
  More Information

Study ID Numbers: MHBS-047-98F
Study First Received: July 3, 2001
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00018616  
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
metformin
compliance
MEMS

Study placed in the following topic categories:
Metformin
Diabetes Mellitus

Additional relevant MeSH terms:
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009